Tormentic acid, a triterpenoid isolated from the fruits of Chaenomeles speciose, protected indomethacin-induced gastric mucosal lesion via modulating miR-139 and the CXCR4/CXCL12/PLC/PKC/Rho a/MLC pathway

作者:He, Jun-Yu; Li, Jie; Zhang, Yuan-Yuan; He, Hai-Bo*; He, Yu-Min; Xu, Dao-Xiang; Wang, Xiao; Wu, Hao-Yang; Zhang, Ji-Hong*; Jahid, Hasan; Sadia, Akter; Yu, Hui-Fan; Wang, Jun-Zhi; Zou, Kun
来源:PHARMACEUTICAL BIOLOGY, 2023, 61(1): 1343-1363.
DOI:10.1080/13880209.2023.2249526

摘要

Context: Tormentic acid (TA), an effective triterpenoid isolated from Chaenomeles speciosa (Sweet) Nakai (Rosaceae) fruits, exerts an effective treatment for gastric damage. @@@ Objective: To investigate the gastroprotective effect of TA on indomethacin (IND) damaged GES-1 cells and rats, and explore potential mechanisms. @@@ Materials and methods: TA concentrations of 1.563-25 mM were used. Cell proliferation, apoptosis and migration were performed using MTT, colony formation, wound healing, migration, Hoechst staining assays. SD rats were divided into control, IND, TA (1, 2 and 4mg/kg) thorn IND groups, once a day for 21 continuous days. Twenty-four hours after the last administration, all groups except the control group were given IND (100mg/kg) by gavage. Gastric juice parameters, gastric ulcer, gastric blood flow (GBF), blood biochemical parameters and cytokine analysis and gastric mucosal histopathology were detected for 2 h and 6 h after IND oral administration. The mRNA and protein expression of miR-139 and the CXCR4/CXCL12/PLC/PKC/Rho A/MLC pathway were analyzed in the IND-damaged GES-1 cells and gastric tissue of rats. @@@ Results: TA might ameliorate the gastric mucosal injury by accelerating the IND-damaged GES-1 cell proliferation and migration, ameliorating GBF, ulcer area and pathologic changes, the redox system and cytokine levels, the gastric juice parameters, elevating the gastric pH in IND damaged rats; suppressed miR139 mRNA expression, elevated CXCR4 and CXCL12 mRNA and protein expression, p-PLC, p-PKC, Rho A, MLCK and p-MLC protein expression. @@@ Discussion and conclusions: TA may have potential use as a clinical drug candidate for gastric mucosal lesion treatment.

全文